医学
新辅助治疗
乳腺癌
肿瘤科
内科学
前瞻性队列研究
临床试验
癌症
作者
Paul Jank,Thomas Karn,Marion van Mackelenbergh,Judith Lindner,Denise Treue,Jens Huober,Knut Engels,Christine Solbach,Kurt Diebold,Frederik Marmé,Volkmar Müller,Andreas Schneeweiß,Hans‐Peter Sinn,Tanja Fehm,Christian Schem,Elmar Stickeler,Peter A. Fasching,Jan Budczies,Bärbel Felder,Valentina Nekljudova
标识
DOI：10.1158/1078-0432.ccr-24-0459
摘要
The PI3K signaling pathway is frequently dysregulated in breast cancer, and mutations in PIK3CA are relevant for therapy resistance in HER2-positive (HER2pos) breast cancer. Mutations in exons 9 or 20 may have different impacts on response to neoadjuvant chemotherapy-based treatment regimens.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
cdercder
Copyright
大力的冬萱
ale
矮小的行云
arniu2008
yjh123
22336
俊秀的白曼
Nexus
aaaa
lx
认真的不评
蓝天
行走的荷尔蒙
sagitar
科研狗
关山北
pokexuejiao
皖公网安备34019202002308
